Our team studies the developmental and behavioral characteristics of various neurodevelopmental disorders (NDDs), including chromosome 22q11.2 deletion syndrome, Down syndrome, and autism spectrum disorder.
Our projects include studies investigating comorbidities such as ADHD and anxiety, as well as clinical medication trials, all aimed at improving daily functioning for individuals with NDDs.

Collaborators:
Anna J. Esbensen, Ph.D., Cincinnati Children Hospital Medical Center
Tanya E. Froehlich, M.D., M.S., FAAP, Cincinnati Children Hospital Medical Center